nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—NOS2—bile duct cancer	0.688	0.777	CbGaD
Dexamethasone—PTGS2—bile duct cancer	0.197	0.223	CbGaD
Dexamethasone—ABCB11—bile duct—bile duct cancer	0.0185	0.217	CbGeAlD
Dexamethasone—ABCB11—bile—bile duct cancer	0.0142	0.166	CbGeAlD
Dexamethasone—ABCC2—bile duct—bile duct cancer	0.0094	0.11	CbGeAlD
Dexamethasone—ABCC2—bile—bile duct cancer	0.00723	0.0847	CbGeAlD
Dexamethasone—ANXA1—gall bladder—bile duct cancer	0.00388	0.0454	CbGeAlD
Dexamethasone—CYP3A43—liver—bile duct cancer	0.00252	0.0295	CbGeAlD
Dexamethasone—PLA2G1B—pancreas—bile duct cancer	0.00234	0.0274	CbGeAlD
Dexamethasone—CYP4A11—liver—bile duct cancer	0.0018	0.021	CbGeAlD
Dexamethasone—ANXA1—pancreas—bile duct cancer	0.00179	0.0209	CbGeAlD
Dexamethasone—PTGS2—gall bladder—bile duct cancer	0.00117	0.0137	CbGeAlD
Dexamethasone—ABCB11—liver—bile duct cancer	0.00116	0.0136	CbGeAlD
Dexamethasone—ANXA1—liver—bile duct cancer	0.00114	0.0133	CbGeAlD
Dexamethasone—CYP3A7—liver—bile duct cancer	0.00113	0.0133	CbGeAlD
Dexamethasone—CYP17A1—liver—bile duct cancer	0.00102	0.0119	CbGeAlD
Dexamethasone—CYP3A7-CYP3A51P—liver—bile duct cancer	0.000962	0.0113	CbGeAlD
Dexamethasone—ANXA1—lymph node—bile duct cancer	0.000872	0.0102	CbGeAlD
Dexamethasone—CYP2A6—liver—bile duct cancer	0.000786	0.00921	CbGeAlD
Dexamethasone—CYP17A1—lymph node—bile duct cancer	0.000782	0.00916	CbGeAlD
Dexamethasone—NR3C2—liver—bile duct cancer	0.000737	0.00863	CbGeAlD
Dexamethasone—CYP11A1—lymph node—bile duct cancer	0.000727	0.00852	CbGeAlD
Dexamethasone—SLCO1A2—liver—bile duct cancer	0.000631	0.0074	CbGeAlD
Dexamethasone—CYP3A5—pancreas—bile duct cancer	0.000626	0.00733	CbGeAlD
Dexamethasone—NR3C1—pancreas—bile duct cancer	0.000621	0.00727	CbGeAlD
Dexamethasone—CYP19A1—liver—bile duct cancer	0.000616	0.00722	CbGeAlD
Dexamethasone—ABCC2—liver—bile duct cancer	0.000588	0.00689	CbGeAlD
Dexamethasone—CYP1B1—liver—bile duct cancer	0.000576	0.00675	CbGeAlD
Dexamethasone—NR3C2—lymph node—bile duct cancer	0.000565	0.00662	CbGeAlD
Dexamethasone—PTGS2—pancreas—bile duct cancer	0.000537	0.0063	CbGeAlD
Dexamethasone—PGR—lymph node—bile duct cancer	0.000525	0.00615	CbGeAlD
Dexamethasone—CYP2C19—liver—bile duct cancer	0.000505	0.00592	CbGeAlD
Dexamethasone—CYP19A1—lymph node—bile duct cancer	0.000472	0.00553	CbGeAlD
Dexamethasone—ABCC2—lymph node—bile duct cancer	0.000451	0.00528	CbGeAlD
Dexamethasone—CYP1B1—lymph node—bile duct cancer	0.000442	0.00517	CbGeAlD
Dexamethasone—CYP2C8—liver—bile duct cancer	0.000441	0.00517	CbGeAlD
Dexamethasone—ABCG2—liver—bile duct cancer	0.000429	0.00502	CbGeAlD
Dexamethasone—CYP1A1—liver—bile duct cancer	0.000407	0.00477	CbGeAlD
Dexamethasone—CYP3A5—liver—bile duct cancer	0.000398	0.00466	CbGeAlD
Dexamethasone—CYP2B6—liver—bile duct cancer	0.000396	0.00464	CbGeAlD
Dexamethasone—NR3C1—liver—bile duct cancer	0.000395	0.00463	CbGeAlD
Dexamethasone—CYP2C9—liver—bile duct cancer	0.000392	0.00459	CbGeAlD
Dexamethasone—CYP2E1—liver—bile duct cancer	0.000371	0.00435	CbGeAlD
Dexamethasone—PTGS2—liver—bile duct cancer	0.000342	0.00401	CbGeAlD
Dexamethasone—ABCB1—pancreas—bile duct cancer	0.000332	0.00389	CbGeAlD
Dexamethasone—ABCG2—lymph node—bile duct cancer	0.000329	0.00385	CbGeAlD
Dexamethasone—CYP1A1—lymph node—bile duct cancer	0.000312	0.00366	CbGeAlD
Dexamethasone—NR3C1—lymph node—bile duct cancer	0.000303	0.00355	CbGeAlD
Dexamethasone—CYP3A4—liver—bile duct cancer	0.000299	0.0035	CbGeAlD
Dexamethasone—CYP2D6—liver—bile duct cancer	0.000294	0.00344	CbGeAlD
Dexamethasone—PTGS2—lymph node—bile duct cancer	0.000262	0.00307	CbGeAlD
Dexamethasone—ABCB1—liver—bile duct cancer	0.000212	0.00248	CbGeAlD
Dexamethasone—ABCB1—lymph node—bile duct cancer	0.000162	0.0019	CbGeAlD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	4.78e-05	0.00167	CbGpPWpGaD
Dexamethasone—PGR—Signaling by ERBB4—KRAS—bile duct cancer	4.72e-05	0.00165	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	4.7e-05	0.00164	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—SLC5A5—bile duct cancer	4.7e-05	0.00164	CbGpPWpGaD
Dexamethasone—NOS2—Circadian rythm related genes—TP53—bile duct cancer	4.63e-05	0.00162	CbGpPWpGaD
Dexamethasone—PTGS2—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	4.58e-05	0.0016	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—IDH2—bile duct cancer	4.57e-05	0.00159	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—IDH2—bile duct cancer	4.52e-05	0.00158	CbGpPWpGaD
Dexamethasone—NR3C1—AP-1 transcription factor network—TP53—bile duct cancer	4.51e-05	0.00157	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	4.41e-05	0.00154	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—IDH1—bile duct cancer	4.3e-05	0.0015	CbGpPWpGaD
Dexamethasone—NOS2—Circadian rythm related genes—IL6—bile duct cancer	4.24e-05	0.00148	CbGpPWpGaD
Dexamethasone—NR3C2—Gene Expression—SMAD4—bile duct cancer	4.22e-05	0.00147	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—FAR2—bile duct cancer	4.14e-05	0.00144	CbGpPWpGaD
Dexamethasone—NR3C1—AP-1 transcription factor network—IL6—bile duct cancer	4.13e-05	0.00144	CbGpPWpGaD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	4.06e-05	0.00142	CbGpPWpGaD
Dexamethasone—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	4.06e-05	0.00141	CbGpPWpGaD
Dexamethasone—PGR—Signaling by ERBB4—HRAS—bile duct cancer	4.02e-05	0.0014	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—IDH2—bile duct cancer	4.01e-05	0.0014	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—FAR2—bile duct cancer	3.98e-05	0.00139	CbGpPWpGaD
Dexamethasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—bile duct cancer	3.98e-05	0.00139	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—IDH1—bile duct cancer	3.93e-05	0.00137	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	3.9e-05	0.00136	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—FAR2—bile duct cancer	3.9e-05	0.00136	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—FAR2—bile duct cancer	3.89e-05	0.00136	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—IDH1—bile duct cancer	3.89e-05	0.00136	CbGpPWpGaD
Dexamethasone—PTGS2—C-MYB transcription factor network—NRAS—bile duct cancer	3.86e-05	0.00135	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—RNF43—bile duct cancer	3.86e-05	0.00135	CbGpPWpGaD
Dexamethasone—PGR—Signaling by ERBB4—IL6—bile duct cancer	3.84e-05	0.00134	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—SLC5A5—bile duct cancer	3.7e-05	0.00129	CbGpPWpGaD
Dexamethasone—ABCC2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	3.69e-05	0.00129	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—MBD2—bile duct cancer	3.69e-05	0.00129	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—FAR2—bile duct cancer	3.68e-05	0.00128	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—GNAS—bile duct cancer	3.65e-05	0.00127	CbGpPWpGaD
Dexamethasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—bile duct cancer	3.64e-05	0.00127	CbGpPWpGaD
Dexamethasone—ABCC2—NRF2 pathway—TGFB1—bile duct cancer	3.48e-05	0.00121	CbGpPWpGaD
Dexamethasone—NOS2—Disease—TGFBR2—bile duct cancer	3.48e-05	0.00121	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	3.47e-05	0.00121	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—IDH1—bile duct cancer	3.45e-05	0.0012	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—FAR2—bile duct cancer	3.37e-05	0.00117	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—IDH2—bile duct cancer	3.35e-05	0.00117	CbGpPWpGaD
Dexamethasone—NR3C1—Adipogenesis—TGFB1—bile duct cancer	3.34e-05	0.00117	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	3.33e-05	0.00116	CbGpPWpGaD
Dexamethasone—PTGS2—C-MYB transcription factor network—KRAS—bile duct cancer	3.33e-05	0.00116	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—MMP9—bile duct cancer	3.32e-05	0.00116	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—bile duct cancer	3.3e-05	0.00115	CbGpPWpGaD
Dexamethasone—NOS2—Disease—SMAD4—bile duct cancer	3.29e-05	0.00115	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—TGFBR2—bile duct cancer	3.23e-05	0.00113	CbGpPWpGaD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	3.21e-05	0.00112	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	3.18e-05	0.00111	CbGpPWpGaD
Dexamethasone—SLCO1A2—Transmembrane transport of small molecules—GNAS—bile duct cancer	3.15e-05	0.0011	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—KRAS—bile duct cancer	3.11e-05	0.00109	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—GNAS—bile duct cancer	3.11e-05	0.00109	CbGpPWpGaD
Dexamethasone—NR3C1—Generic Transcription Pathway—SMAD4—bile duct cancer	3.08e-05	0.00108	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—SMAD4—bile duct cancer	3.05e-05	0.00106	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—IDH2—bile duct cancer	3.03e-05	0.00106	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—FAR2—bile duct cancer	3.01e-05	0.00105	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—FAR2—bile duct cancer	2.94e-05	0.00102	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—IDH2—bile duct cancer	2.91e-05	0.00102	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—NRAS—bile duct cancer	2.89e-05	0.00101	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—IDH1—bile duct cancer	2.88e-05	0.001	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—GNAS—bile duct cancer	2.88e-05	0.001	CbGpPWpGaD
Dexamethasone—ABCC2—Transmembrane transport of small molecules—GNAS—bile duct cancer	2.87e-05	0.001	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	2.84e-05	0.000989	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—SLC5A5—bile duct cancer	2.83e-05	0.000988	CbGpPWpGaD
Dexamethasone—PTGS2—C-MYB transcription factor network—HRAS—bile duct cancer	2.83e-05	0.000986	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—TP53—bile duct cancer	2.77e-05	0.000965	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—FAR2—bile duct cancer	2.77e-05	0.000965	CbGpPWpGaD
Dexamethasone—CYP2A6—NRF2 pathway—TGFB1—bile duct cancer	2.75e-05	0.000959	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—FAR2—bile duct cancer	2.74e-05	0.000956	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—TGFB1—bile duct cancer	2.74e-05	0.000954	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—TGFB1—bile duct cancer	2.69e-05	0.000938	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—EGFR—bile duct cancer	2.68e-05	0.000936	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—TGFB1—bile duct cancer	2.67e-05	0.000932	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	2.66e-05	0.000926	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—IDH2—bile duct cancer	2.65e-05	0.000925	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	2.63e-05	0.000918	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—IDH2—bile duct cancer	2.63e-05	0.000916	CbGpPWpGaD
Dexamethasone—PTGS2—Selenium Micronutrient Network—IL6—bile duct cancer	2.61e-05	0.000909	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—IDH1—bile duct cancer	2.6e-05	0.000908	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—SLC5A5—bile duct cancer	2.59e-05	0.000904	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	2.59e-05	0.000902	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—SMAD4—bile duct cancer	2.57e-05	0.000896	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—SLC5A5—bile duct cancer	2.57e-05	0.000895	CbGpPWpGaD
Dexamethasone—NR3C1—Adipogenesis—IL6—bile duct cancer	2.52e-05	0.000878	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—IDH1—bile duct cancer	2.51e-05	0.000874	CbGpPWpGaD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—GNAS—bile duct cancer	2.5e-05	0.00087	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—KRAS—bile duct cancer	2.49e-05	0.000868	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	2.43e-05	0.000847	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—RNF43—bile duct cancer	2.41e-05	0.000842	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—IDH2—bile duct cancer	2.41e-05	0.00084	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	2.4e-05	0.000838	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—IDH1—bile duct cancer	2.28e-05	0.000795	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—SLC5A5—bile duct cancer	2.28e-05	0.000794	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—IDH1—bile duct cancer	2.26e-05	0.000788	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—TP53—bile duct cancer	2.25e-05	0.000785	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—TP53—bile duct cancer	2.21e-05	0.000772	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—GNAS—bile duct cancer	2.2e-05	0.000768	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—NRAS—bile duct cancer	2.2e-05	0.000768	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—IL6—bile duct cancer	2.18e-05	0.000759	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	2.13e-05	0.000744	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—HRAS—bile duct cancer	2.12e-05	0.000738	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—IDH1—bile duct cancer	2.08e-05	0.000724	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—IDH1—bile duct cancer	2.07e-05	0.000722	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—IL6—bile duct cancer	2.06e-05	0.000719	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—IDH2—bile duct cancer	2.02e-05	0.000705	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—GNAS—bile duct cancer	2.01e-05	0.000702	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—EGFR—bile duct cancer	2.01e-05	0.000699	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—GNAS—bile duct cancer	1.99e-05	0.000695	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—PTGS2—bile duct cancer	1.96e-05	0.000684	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—IDH2—bile duct cancer	1.94e-05	0.000678	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—IDH2—bile duct cancer	1.9e-05	0.000664	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—SLC5A5—bile duct cancer	1.9e-05	0.000662	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—IDH2—bile duct cancer	1.9e-05	0.000662	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—KRAS—bile duct cancer	1.89e-05	0.000661	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	1.87e-05	0.000651	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	1.86e-05	0.000649	CbGpPWpGaD
Dexamethasone—NOS2—Disease—ERBB2—bile duct cancer	1.84e-05	0.000642	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	1.83e-05	0.000636	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	1.83e-05	0.000636	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—FAR2—bile duct cancer	1.81e-05	0.000631	CbGpPWpGaD
Dexamethasone—NOS2—Disease—PTGS2—bile duct cancer	1.8e-05	0.000628	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—IDH2—bile duct cancer	1.79e-05	0.000626	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.78e-05	0.000621	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—GNAS—bile duct cancer	1.77e-05	0.000617	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TGFBR2—bile duct cancer	1.76e-05	0.000615	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—IDH1—bile duct cancer	1.74e-05	0.000606	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	1.74e-05	0.000606	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	1.72e-05	0.000601	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—SLC5A5—bile duct cancer	1.72e-05	0.000599	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—ERBB2—bile duct cancer	1.71e-05	0.000596	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—GNAS—bile duct cancer	1.7e-05	0.000593	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—IDH1—bile duct cancer	1.67e-05	0.000583	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—SMAD4—bile duct cancer	1.67e-05	0.000582	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—SLC5A5—bile duct cancer	1.65e-05	0.000577	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—IDH2—bile duct cancer	1.65e-05	0.000574	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—IDH1—bile duct cancer	1.64e-05	0.000571	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—IDH1—bile duct cancer	1.63e-05	0.00057	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—HRAS—bile duct cancer	1.61e-05	0.000562	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.61e-05	0.000561	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.55e-05	0.00054	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—PTGS2—bile duct cancer	1.54e-05	0.000539	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—IDH1—bile duct cancer	1.54e-05	0.000538	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—IL6—bile duct cancer	1.54e-05	0.000538	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	1.53e-05	0.000534	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—SLC5A5—bile duct cancer	1.5e-05	0.000525	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—SLC5A5—bile duct cancer	1.49e-05	0.00052	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—SMAD4—bile duct cancer	1.48e-05	0.000518	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—GNAS—bile duct cancer	1.48e-05	0.000515	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—IDH2—bile duct cancer	1.47e-05	0.000512	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—MMP9—bile duct cancer	1.47e-05	0.000511	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—IDH2—bile duct cancer	1.43e-05	0.0005	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—IDH1—bile duct cancer	1.41e-05	0.000493	CbGpPWpGaD
Dexamethasone—NOS2—Disease—NRAS—bile duct cancer	1.4e-05	0.000488	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—SLC5A5—bile duct cancer	1.37e-05	0.000477	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—IDH2—bile duct cancer	1.35e-05	0.000471	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—GNAS—bile duct cancer	1.35e-05	0.000471	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—IDH2—bile duct cancer	1.34e-05	0.000467	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—GNAS—bile duct cancer	1.33e-05	0.000465	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	1.32e-05	0.00046	CbGpPWpGaD
Dexamethasone—NOS2—Disease—TGFB1—bile duct cancer	1.3e-05	0.000454	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—NRAS—bile duct cancer	1.3e-05	0.000453	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	1.29e-05	0.000451	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—GNAS—bile duct cancer	1.28e-05	0.000448	CbGpPWpGaD
Dexamethasone—NOS2—Disease—EGFR—bile duct cancer	1.28e-05	0.000445	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—IDH1—bile duct cancer	1.26e-05	0.00044	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—IDH1—bile duct cancer	1.23e-05	0.00043	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	1.22e-05	0.000426	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—TGFB1—bile duct cancer	1.21e-05	0.000421	CbGpPWpGaD
Dexamethasone—NOS2—Disease—KRAS—bile duct cancer	1.21e-05	0.00042	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—EGFR—bile duct cancer	1.18e-05	0.000413	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—PTGS2—bile duct cancer	1.18e-05	0.000412	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—GNAS—bile duct cancer	1.17e-05	0.000408	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—IDH1—bile duct cancer	1.16e-05	0.000405	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—GNAS—bile duct cancer	1.16e-05	0.000404	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—IDH1—bile duct cancer	1.15e-05	0.000402	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—SLC5A5—bile duct cancer	1.15e-05	0.0004	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—KRAS—bile duct cancer	1.12e-05	0.00039	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—TGFBR2—bile duct cancer	1.1e-05	0.000385	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—SLC5A5—bile duct cancer	1.1e-05	0.000385	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	1.09e-05	0.000379	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—PTGS2—bile duct cancer	1.08e-05	0.000377	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—SLC5A5—bile duct cancer	1.08e-05	0.000377	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—SLC5A5—bile duct cancer	1.08e-05	0.000376	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—PTGS2—bile duct cancer	1.07e-05	0.000373	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—GNAS—bile duct cancer	1.06e-05	0.00037	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—SMAD4—bile duct cancer	1.04e-05	0.000364	CbGpPWpGaD
Dexamethasone—NOS2—Disease—HRAS—bile duct cancer	1.02e-05	0.000357	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—SLC5A5—bile duct cancer	1.02e-05	0.000355	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—TP53—bile duct cancer	9.95e-06	0.000347	CbGpPWpGaD
Dexamethasone—NOS2—Disease—IL6—bile duct cancer	9.81e-06	0.000342	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	9.54e-06	0.000333	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—HRAS—bile duct cancer	9.51e-06	0.000332	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PTGS2—bile duct cancer	9.5e-06	0.000331	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—ERBB2—bile duct cancer	9.35e-06	0.000326	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—SLC5A5—bile duct cancer	9.34e-06	0.000326	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—IL6—bile duct cancer	9.11e-06	0.000318	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—GNAS—bile duct cancer	8.92e-06	0.000311	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—IDH2—bile duct cancer	8.83e-06	0.000308	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	8.75e-06	0.000305	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—GNAS—bile duct cancer	8.57e-06	0.000299	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—GNAS—bile duct cancer	8.39e-06	0.000293	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—GNAS—bile duct cancer	8.37e-06	0.000292	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—SLC5A5—bile duct cancer	8.33e-06	0.000291	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—SLC5A5—bile duct cancer	8.13e-06	0.000284	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MMP9—bile duct cancer	8.02e-06	0.00028	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PTGS2—bile duct cancer	7.93e-06	0.000276	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—GNAS—bile duct cancer	7.91e-06	0.000276	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	7.81e-06	0.000272	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—NOS2—bile duct cancer	7.77e-06	0.000271	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—SLC5A5—bile duct cancer	7.66e-06	0.000267	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—SLC5A5—bile duct cancer	7.6e-06	0.000265	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—IDH1—bile duct cancer	7.59e-06	0.000265	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—GNAS—bile duct cancer	7.25e-06	0.000253	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PTGS2—bile duct cancer	7.17e-06	0.00025	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	7.12e-06	0.000248	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—NRAS—bile duct cancer	7.11e-06	0.000248	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PTGS2—bile duct cancer	6.9e-06	0.000241	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TGFB1—bile duct cancer	6.61e-06	0.00023	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—EGFR—bile duct cancer	6.48e-06	0.000226	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GNAS—bile duct cancer	6.47e-06	0.000226	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GNAS—bile duct cancer	6.32e-06	0.00022	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PTGS2—bile duct cancer	6.28e-06	0.000219	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PTGS2—bile duct cancer	6.22e-06	0.000217	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—KRAS—bile duct cancer	6.12e-06	0.000213	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GNAS—bile duct cancer	5.96e-06	0.000208	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GNAS—bile duct cancer	5.9e-06	0.000206	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—ERBB2—bile duct cancer	5.85e-06	0.000204	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PTGS2—bile duct cancer	5.7e-06	0.000199	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TP53—bile duct cancer	5.44e-06	0.00019	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—HRAS—bile duct cancer	5.2e-06	0.000181	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—SLC5A5—bile duct cancer	5.01e-06	0.000175	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IL6—bile duct cancer	4.98e-06	0.000174	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PTGS2—bile duct cancer	4.6e-06	0.00016	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PTGS2—bile duct cancer	4.51e-06	0.000157	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PTGS2—bile duct cancer	4.5e-06	0.000157	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—NRAS—bile duct cancer	4.45e-06	0.000155	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PTGS2—bile duct cancer	4.25e-06	0.000148	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—TGFB1—bile duct cancer	4.13e-06	0.000144	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—EGFR—bile duct cancer	4.05e-06	0.000141	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTGS2—bile duct cancer	3.9e-06	0.000136	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GNAS—bile duct cancer	3.89e-06	0.000136	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—KRAS—bile duct cancer	3.83e-06	0.000133	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTGS2—bile duct cancer	3.48e-06	0.000121	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTGS2—bile duct cancer	3.39e-06	0.000118	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—HRAS—bile duct cancer	3.25e-06	0.000113	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTGS2—bile duct cancer	3.2e-06	0.000112	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTGS2—bile duct cancer	3.17e-06	0.000111	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—IL6—bile duct cancer	3.11e-06	0.000109	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTGS2—bile duct cancer	2.09e-06	7.29e-05	CbGpPWpGaD
